Former Cytodyn Execs Charged With Fraud For Misrepresenting HIV, COVID Trials
A federal grand jury in the District of Maryland produced an indictment that was unsealed Tuesday, charging two men with
Read more
CytoDyn
CytoDyn Is Ready To Welcome Back The Former Chief Medical Officer It Terminated
It seems CytoDyn Inc. (OTCQB: CYDY) is ready to extend an olive branch to its former chief medical officer. The
Read more
FDA Puts CytoDyn Clinical Trials For HIV, COVID-19 On Hold
CytoDyn Inc. (OTCQB: CYDY) reported on Wednesday that its current trials for investigational drug leronlimab will be put on partial
Read more
CytoDyn Begins Phase 3 Trial Of Antibody Treatment For Critically Ill COVID-19 Patients
CytoDyn Inc. (OTCQB: CYDY) reported this morning that it has started its phase 3 clinical trial to consider the company’s
Read more
CytoDyn Files Legal Actions Against Its Former Contract Research Organization
CytoDyn Inc. (OTCQB: CYDY) announced this morning that it has filed a legal complaint about an alleged breach of contract
Read more
CytoDyn Starts Phase 3 Trial Of Antibody Treatment For COVID-19 Patients With Severe Symptoms In Brazil
CytoDyn Inc. (OTCQB: CYDY) reported on Thursday night that it started a phase 3 clinical trial to consider the company’s
Read more
Three Things to Know About ‘Phase 3 COVID Player’: Revive Therapeutics
Bucillamine Just Got Cleared for Phase 3 Trials of COVID-19 On Friday, July 31, 2020 Revive Therapeutics (CSE: RVV) (OTC:
Read more